In a 3×2 randomized trial of aspirin (81 or 325 mg, placebo) and folic acid (1 mg, placebo) to prevent recurrence of colonic adenoma (43), it was found that higher dose aspirin (325 mg) reduced serum C reactive protein, but this was abrogated by folic acid (43). The gene discussed is CRP; the disease is colon adenoma.